- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Cipla Limited — Updates, 31-08-2026: Press Release
31-08-2026 | 03:53 pm
31-08-2026 | 03:53 pm
Cipla secured an exclusive licensing agreement with SBP Group for TQB2102, a promising HER2 bispecific ADC. This boosts Cipla's oncology pipeline for breast cancer patients across India, South Africa, and key emerging markets, enhancing access to innovative therapies.
No comments yet. Be the first to comment!